COLL FY 2024 Earnings — Collegium Pharmaceutical, Inc. Revenue & Financial Results | Market Cap Arena

COLLCollegium Pharmaceutical, Inc.

$1B

FY 2024 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$631M+11.4% YoY

Gross Profit

$377M59.8% margin

Operating Income

$170M26.9% margin

Net Income

$69M11.0% margin

EPS (Diluted)

$1.86

Cash Flow

Operating Cash Flow

$205M

Free Cash Flow

$203M

Stock-Based Comp.

$32M

Balance Sheet

Total Assets

$1.7B

Total Liabilities

$1.4B

Stockholders' Equity

$229M

Cash & Equivalents

$71M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$631M	$567M	+11.4%
Gross Profit	$377M	$326M	+15.7%
Operating Income	$170M	$167M	+1.8%
Net Income	$69M	$48M	+43.7%